Similarly, western blot analysis of the protein levels of CBX7 in patient samples with clear renal cell carcinoma from our hospital indicated that CBX7 was decreased in cancer tissues compared to adjacent nontumor (NAT) renal tissues (Fig. 1D). The gene discussed is BRD2; the disease is clear cell renal carcinoma.